Researchers from the University of Ottawa and The Ottawa Hospital have been awarded $1,050,000 million from the Canada Foundation for Innovation to support facilities for manufacturing innovative treatments and vaccines for COVID-19.
The funding will support new equipment and infrastructure at The Ottawa Hospitals Biotherapeutics Manufacturing Centre (BMC), which has been successfully manufacturing therapies using cells, genes and viruses for clinical trials in Canada and abroad for more than 10 years…..